Results 231 to 240 of about 191,380 (292)

Bimekizumab for recalcitrant pyoderma gangrenosum. [PDF]

open access: yesJAAD Case Rep
Tolete C   +3 more
europepmc   +1 more source

Targeting Immunologic Pathways in Eosinophilic Granulomatosis With Polyangiitis: Translating Emerging Evidence Into Clinical Practice

open access: yesAllergy, EarlyView.
ABSTRACT Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare and potentially life‐threatening systemic, inflammatory disease with multi‐organ manifestations, variable presentation and complex pathology. Multiple interconnected immunological pathways are implicated in EGPA pathology, including a type‐2 immune response driving predominantly ...
Harold Wilson‐Morkeh   +7 more
wiley   +1 more source

Severe Immune Neutropenia Responsive to Ruxolitinib. [PDF]

open access: yesEJHaem
Schwarzkopf R   +4 more
europepmc   +1 more source

Small Airways Dysfunction and Remission in Adults With Asthma: A Longitudinal Exploratory Analysis of the AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS) Study

open access: yesAllergy, EarlyView.
We conducted a post hoc analysis of ATLANTIS, a multinational prospective study including 684 adults with asthma. Fewer small airway symptoms and lower disease activity are independently associated with asthma remission. Replicated airway transcriptomic signatures show increased IL‐4/13 signalling and reduced coagulation pathways across the ATLANTIS ...
Akshi Kumar   +14 more
wiley   +1 more source

Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01. [PDF]

open access: yesFuture Oncol
Azad AA   +10 more
europepmc   +1 more source

Serpina3c protects against metabolic dysfunction-associated steatotic liver disease in offspring induced by prenatal prednisone exposure. [PDF]

open access: yesSignal Transduct Target Ther
Dai Y   +16 more
europepmc   +1 more source

Heterogeneous response to efgartigimod in real-world experience with myasthenia gravis: Predictors and treatment strategies. [PDF]

open access: yesNeurotherapeutics
Fuchs L   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy